Associate Professor, Surgery, University of Louisville School of Medicine
General Surgery
Dr. Charles R. Scoggins, MD
|
|
Give Review
Charles R. Scoggins, MD practices General Surgery. He researched medicine at University of Texas Medical School. He over the years received 2 awards: "Regional Top Doctor" and "Fellow (FACS)". Charles Scoggins is a published doctor. He has 101 papers published. The most current publication "The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study ..."
Publications
- Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt ...
- Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...
- The relationship of blood transfusion with peri-operative and long-term outcomes after major hepatectomy for metastatic colorectal cancer: a multi-institutional study ...
- Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
- A multi-institutional analysis of 429 patients undergoing major hepatectomy for colorectal cancer liver metastases: The impact of concomitant bile duct resection on su...
- Infectious complications in combined colon resection and ablation of colorectal liver metastases.
- Risk stratification for readmission after major hepatectomy: development of a readmission risk score.
- Laparoscopic Versus Open Hepatic Resection for Hepatocellular Carcinoma: Improvement in Outcomes and Similar Cost.
- The role of hepatic artery lymph node in pancreatic adenocarcinoma: prognostic factor or a selection criterion for surgery.
- Preoperative dosing of low-molecular-weight heparin in hepatopancreatobiliary surgery.
- Small versus large-sized drug-eluting beads (DEBIRI) for the treatment of hepatic colorectal metastases: a propensity score matching analysis.
- Factors predictive of readmission after hepatic resection for hepatocellular carcinoma.
- Value of intraoperative neck margin analysis during whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
- Restrictive blood transfusion protocol in liver resection patients reduces blood transfusions with no increase in patient morbidity.
- Perioperative Blood Transfusion Is Associated with Decreased Survival in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: a Multi-institution...
- A Cost Analysis of Somatostatin use in the Prevention of Pancreatic Fistula after Pancreatectomy.
- Addition of an Iliac/Obturator Lymph Node Dissection Does Not Improve Nodal Recurrence or Survival in Melanoma.
- Evaluation of Quality of Life Following Placement of Self-Expanding Plastic Stents as a Bridge to Surgery in Patients Receiving Neoadjuvant Therapy for Esophageal Cancer.
- Prognostic factors in young women with cutaneous melanoma.
- Comparison of Sentinel Lymph Node Micrometastatic Tumor Burden Measurements in Melanoma.
- Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: A guide to adjuvant clinical trials.
- Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring.
- Outcomes and prognostic factors in superficial spreading melanoma.
- Incidence of sentinel lymph node involvement in a modern, large series of desmoplastic melanoma.
- Evaluation of Alpha-fetoprotein Staging System for Hepatocellular Carcinoma in Noncirrhotic Patients.
- Laparoscopic hepatectomy is a safe and effective approach for resecting large colorectal liver metastases.
- Financial Comparison of Laparoscopic Versus Open Hepatic Resection Using Deviation-Based Cost Modeling.
- Improving Clinical Productivity in an Academic Surgical Practice Through Transparency.
- Vein Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of "Borderline Resectable Disease"?
- Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
- Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer.
- Assessment of Chemotherapy Response in Colorectal Liver Metastases in Patients Undergoing Hepatic Resection and the Correlation to Pathologic Residual Viable Tumor.
- Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis.
- Combined pancreas and liver therapies: Resection and ablation in hepato-pancreatico-biliary malignancies.
- Negative effects of transfused blood components after hepatectomy for metastatic colorectal cancer.
- Assessment of mitotic rate reporting in melanoma.
- Unique prognostic factors in acral lentiginous melanoma.
- The lymph node ratio has limited prognostic significance in melanoma.
- Clinicopathologic and survival differences between upper and lower extremity melanomas.
- Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer.
- Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
- Impact of histology on survival in retroperitoneal sarcoma.
- Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab.
- Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy.
- Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
- Lymphovascular invasion as a prognostic factor in melanoma.
- Safety and efficacy of hepatectomy for colorectal metastases in the elderly.
- Recurrence Following Hepatectomy for Metastatic Colorectal Cancer: Development of a Model that Predicts Patterns of Recurrence and Survival.
- Lymph Node Ratio: A Proposed Refinement of Current Axillary Staging in Breast Cancer Patients.
- Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique?
- Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy.
- Is prior cholecystectomy associated with decreased survival in patients with resectable pancreatic adenocarcinoma following pancreaticoduodenectomy?
- Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer.
- A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
- Ablative therapies for colorectal liver metastases.
- Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis.
- A Prospective Phase II Evaluation of Esophageal Stenting for Neoadjuvant Therapy for Esophageal Cancer: Optimal Performance and Surgical Safety.
- Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.
- Prognostic significance of tumor infiltrating lymphocytes in melanoma.
- Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
- Phase II comparison study of intraoperative autotransfusion for major oncologic procedures.
- Imaged guided transarterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for hepatic metastases from melanoma: early outcomes from a mult...
- The prognostic significance of nonsentinel lymph node metastasis in melanoma.
- Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis.
- Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?
- The lower incidence of melanoma in women may be related to increased preventative behaviors.
- Surveillance after surgical treatment of melanoma: futility of routine chest radiography.
- Bile cultures: a guide to infectious complications after pancreaticoduodenectomy.
- Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
- Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
- Second primary melanomas: incidence and outcome.
- Prior biliary tree instrumentation does not preclude hepatic arterial therapy for malignancy.
- A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?
- Laparoscopic hepatic lobectomy: advantages of a minimally invasive approach.
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
- Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
- Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis.
- Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience.
- Should hepatic metastatic colorectal cancer patients with extrahepatic disease undergo liver resection/ablation?
- Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula.
- Do melanoma patients from Southern climates have a worse outcome than those from Northern climates?
- An evaluation of 2537 gastrointestinal stromal tumors for a proposed clinical staging system.
- Surgical prophylaxis for inheritable malignant diseases: breast cancer and endocrine disease.
- Sentinel lymphadenectomy for cutaneous melanoma: who, what, and why.
- Surgical prophylaxis for inheritable malignant diseases: colorectal and gastric cancer.
- Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?
- Simultaneous versus staged resection for synchronous colorectal cancer liver metastases.
- Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?
- Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy.
- Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
- Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
- Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicated?
- A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients.
- Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases.
- A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients.
- Preoperative performance status predicts outcome following heated intraperitoneal chemotherapy.
- Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients.
- Adequate lymphadenectomy results in accurate nodal staging without an increase in morbidity in patients with gastric adenocarcinoma.
- A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients.
- Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches.
Schools
University Of Texas Medical School At Houston
Vanderbilt University
Vanderbilt University Medical Center
University of Texas MD Anderson Cancer Center
Procedures Preformed
- Laparoscopic Abdominal Surgery
- Plasmapheresis
- Thoracentesis
Doctors Specialties
- Surgery
- Surgical Oncology
- General Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FACS)
Education
-
Vanderbilt University -
University of Texas Medical School
Hospital
-
Jewish Hospital -
Norton Hospital -
University of Louisville Hospital
Drug Facts
| NPI NUMBER | 1831179860 | |
| NPPES Provider LastName | SCOGGINS | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 402025700 | |
| NPPES Provider State | KY | |
| Specialty Description | General Surgery | |
| Total Claim Count | 156.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 27.0 | |
| Percent Opioid Claims | 17.31 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831179860 |
| Last Name Of The Provider | SCOGGINS |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
Dr. James J. Klemens, MD |
|
|
Dr. Dennis W. Conard, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter G. Deveaux, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael H. McCafferty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin E. Gaar III, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Toni M. Ganzel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodney D. McMillin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert C. Martin II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthew V. Benns, MD
This Doctor is OpenDoctor Recommended.
|